Price $104.87 |
Market Cap
14.87B
|
Sector Health Care |
Div. Growth
10.40%
|
|
P/E
21.9
|
P/B
3.19
|
P/S
1.98
|
Dividend %
1.60%
|
|
P/CF
531.0
|
P/FCF
27.3
|
Op. Cash Flow
1.1M
|
FCF
4.0
|
|
Op. Margin
15.80%
|
Net Margin
9.20%
|
ROE
15.10%
|
ROI
10.10%
|
|
ROA
6.90%
|
EPS Growth
-11.60%
|
Current Ratio
1.6
|
Debt/Equity
80.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Xtant Medical Holdings Inc (XTNT) | $0.65 | - | - | 13.5M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.58 | - | - | 4.8M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| iCAD Inc (ICAD) | $3.65 | - | - | 64.7M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.37 | - | - | 17.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
